Product Details

Cefixime + Ofloxacin Tablets BP 400 mg deliver a high-quality combination therapy that meets British Pharmacopoeia (BP) standards. This fixed-dose combination manages bacterial infections requiring broad-spectrum coverage, combining cephalosporin and fluoroquinolone antibacterial action in a single tablet.

The tablets combine:

• Cefixime, a third-generation cephalosporin antibiotic that eliminates bacteria by inhibiting bacterial cell wall synthesis, and
• Ofloxacin, a fluoroquinolone antibiotic that eliminates bacteria by inhibiting bacterial DNA gyrase and topoisomerase IV, extending coverage to organisms resistant to Cefixime alone.

Doctors commonly prescribe this combination for respiratory tract infections, urinary tract infections, typhoid fever, and other bacterial infections where dual-mechanism coverage improves clinical outcomes. Hospitals, clinics, and pharmacies rely on this formulation for its consistent quality and dependable therapeutic results. Our manufacturing process follows strict quality standards to guarantee high purity, accurate dosing, and reliable therapeutic efficacy in every batch.

Key Features

• BP-standard compliant combination therapy
• Treats bacterial infections requiring broad-spectrum coverage
• Delivers combined cephalosporin and fluoroquinolone antibacterial action
• Accurate 400 mg dosage per tablet
• Maintains a high-purity, stable formulation
• Uses hygienic blister packaging for safe storage
• Suits hospital, clinical, and pharmacy use